Clinical Trials Browser

Colorectal Neoplasms × Axitinib × Clear all

NCT04355156 2026-04-16

AXMUS-C

Phase 2 Completed

52 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT04458259 2025-08-28

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Phase 1 Terminated

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT04873895 2024-04-26

TACE-Ax-HCQ

Phase 1 Terminated

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01490866 2019-09-24

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Phase 2 Completed

70 enrolled 9 charts

Gastrointestinal

Colorectal Neoplasms

NCT01483638 2016-05-12

TTD-11-01

Phase 2 Terminated

Gastrointestinal

Colorectal Neoplasms

NCT01486251 2016-02-10

AXUS

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms

NCT00460603 2013-12-06

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

Phase 1/2 Completed

187 enrolled 47 charts

Gastrointestinal

Colorectal Neoplasms

NCT00615056 2013-04-19

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

Phase 2 Completed

171 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms